Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tatsuru Ikeda is active.

Publication


Featured researches published by Tatsuru Ikeda.


The American Journal of Surgical Pathology | 2005

Gastrointestinal stromal tumors of neurofibromatosis type I (von Recklinghausen's disease).

Yutaka Takazawa; Shinji Sakurai; Yuji Sakuma; Tatsuru Ikeda; Jun Yamaguchi; Yoshio Hashizume; Shigeo Yokoyama; Atsushi Motegi; Masashi Fukayama

Gastrointestinal stromal tumor (GIST), as well as the hyperplastic lesions of intestinal neural tissue and its supporting structures, is a gastrointestinal complication of type 1 neurofibromatosis (NF1) (von Recklinghausens disease). In the present study, we analyzed the histologic and immunohistochemical features, and the c-kit and PDGFRA gene mutations of 36 GISTs derived from 9 NF1 patients. Distinctively, multiple GISTs arose preferentially in the small intestine. The histologic features of NF1-associated GISTs are almost similar to those of non-NF1 GISTs, but characteristically most of the NF1-associated GISTs contained skeinoid fibers. Thirty-three GISTs (92%) showed immunoreactivity for KIT, and 23 tumors (64%) showed diffuse or mosaic-like immunoreactivity for S-100 protein. Hyperplasic lesions, which may be the hyperplasia of interstitial cells of Cajal, were observed around some GISTs. Exons 9, 11, 13, and 17 of the c-kit gene and exons 12 and 18 of the PDGFRA gene were amplified and directly sequenced. Point mutations of c-kit gene or PDGFRA gene were identified only in three (8%) and two (6%) tumors, respectively. NF1-associated GISTs, showing the dual differentiation of interstitial cells of Cajal and Schwann cells, develop in close association with the myenteric nerve structure of gastrointestinal tract of NF1 patients. The point mutations of c-kit and PDGFRA gene may play a limited role in the tumorigenesis of NF1-associated GISTs.


Modern Pathology | 2005

Combined expression of p53, cyclin D1 and epidermal growth factor receptor improves estimation of prognosis in curatively resected oral cancer

Masayuki Shiraki; Tetsuyo Odajima; Tatsuru Ikeda; Aya Sasaki; Masaaki Satoh; Akira Yamaguchi; Makoto Noguchi; Itaru Nagai; Hiroyoshi Hiratsuka

p53, cyclin D1 and epidermal growth factor receptor (EGFR) are molecular markers that regulate the cell cycle or cell growth and play important roles in tumor development and progression. In this study, we examined the impact of immunohistochemical expression of these markers on tumor progression in 140 oral cancers. p53, cyclin D1 and EGFR were expressed in 64 cases (46%), 54 cases (39%) and 54 cases (39%), respectively, but there was no inter-relationship between any two of these markers. In the association of these markers with clinicopathological features, EGFR expression alone was significantly associated with poor differentiation (P=0.0008) and invasive growth pattern (P=0.0003). Any of these markers, including EGFR, had no significant impact on survival. Coexpression of all these markers, however, was significantly associated with invasive growth pattern (P=0.0149) and shortened survival (P=0.0181), and was a significant and independent unfavorable prognostic factor (P=0.0002), along with tumor size (P=0.0040), nodal metastasis (P=0.0137) and growth pattern (P=0.0017) in a multivariate analysis. Simultaneous coexpression of these markers in oral cancers might prove to be a useful indicator for identification of low- or high-risk patients.


Pathology International | 2000

p73: Structure and function

Shingo Ichimiya; Akira Nakagawara; Yuji Sakuma; Sachiko Kimura; Tatsuru Ikeda; Masaaki Satoh; Nobuaki Takahashi; Noriyuki Sato; Michio Mori

Alteration of the p53 tumor suppressor gene is a common, if not general, observation in human malignant tumors. p73 Is a novel member of the p53 family at chromosome 1p36.3, at which locus frequent defects are seen in many tumors including neuroblastoma. Besides structural similarities, the fact that p73 functions in the regulation of the cell cycle and apoptosis promotes the expansion of the research field concerning p53‐associated tumor progression. In this paper, we review the structure and function of p73 as well as the mutational status in various human tumors. In addition, possibilities for new therapeutic applications with p73 for cancer cell control are discussed.


Oncology | 2004

The Reproducibility of a Binary Tumor Grading System for Uterine Endometrial Endometrioid Carcinoma, Compared with FIGO System and Nuclear Grading

Satoru Sagae; Tsuyoshi Saito; Masaaki Satoh; Tatsuru Ikeda; Sachiko Kimura; Mitsuru Mori; Noriyuki Sato; Ryuichi Kudo

Objective: A binary grading system has been proposed to assess the amount of solid growth, the pattern of invasion, and the presence of necrosis, and thereby divide endometrial endometrioid carcinomas into low- and high-grade tumors. We analyzed this system for predicting the prognosis, with respect to inter- and intraobserver reproducibility and treatment modalities. Methods: A total of 200 endometrial carcinomas, based on hysterectomy specimens, were graded according to the binary grading system, for comparison against The International Federation of Gynecology and Obstetrics (FIGO) system and nuclear grading. Results: Both inter- and intraobserver agreement using the binary grading system (ĸ = 0.57; percent agreement: 82% and ĸ = 0.62; 84%) were superior compared with the FIGO system (0.50; 60% and 0.62; 73%) and the nuclear grading (0.23; 49% and 0.43; 65%). Patients with early-stage low-grade tumors had a 98% rate for 5-year survival (5YS). Patients with early-stage high-grade tumors, and those with advanced-stage low-grade tumors, had respectively 86% to 87% rates for 5YS. But patients with advanced-stage high-grade tumors had a 49% rate for 5YS. In binary low-grade early-stage tumors, the patient outcome was better with no adjuvant therapy and chemotherapy, compared with other therapies. Conclusion: A binary grading system was superior to others in permitting greater reproducibility and predicting the prognosis of endometrial cancer patients.


Experimental Cell Research | 1989

c-H-ras gene is expressed at the G1 phase in primary cultures of hepatocytes

Tatsuru Ikeda; Norimasa Sawada; Kei Fujinaga; Takashi Minase; Michio Mori

The expression of c-H-ras and proliferating cell nuclear antigen (PCNA) in primary cultures of rat hepatocytes was determined in order to elucidate the relationship between the c-H-ras gene and the S phase of the cell cycle. In cells treated with EGF, elevation of c-H-ras expression was detected at the 22nd, 34th, 44th, and 54th h after plating, PCNA expression and DNA synthesis were detected at the 44th and 54th h. In cells without EGF treatment, only c-H-ras expression was detected at the 44th and 54th h. In our previous report, we showed that c-myc expression increased within several hours after plating, suggesting that isolated hepatocytes traverse from G0 to G1 under culture conditions, regardless of EGF treatment. These results clearly showed that the c-H-ras gene of adult rat hepatocytes was expressed in the mid-to-late G1 phase of the cell cycle as well as in the early S phase in primary culture.


International Journal of Urology | 2005

Bladder cancer discovered by ovarian metastasis : Cytokeratin expression is useful when making differential diagnosis

Yasuhiko Ishii; Naoki Itoh; Atsushi Takahashi; Naoya Masumori; Tatsuru Ikeda; Taiji Tsukamoto

Abstract A 49‐year‐old woman underwent hysterectomy and bilateral adnexectomy after the diagnosis of a right ovarian tumor with paraaortic and pelvic lymph node metastases. The pathological diagnosis was undifferentiated carcinoma of the ovary. After the operation, a bladder tumor was discovered during the evaluation for microscopic hematuria. The bladder tumor was pathologically diagnosed as transitional cell carcinoma, pT1b, G3. Although the pathological findings of the bladder cancer and ovarian cancer were very similar, we could diagnose primary bladder cancer with ovary and lymph node metastases according to the immunohistochemical staining pattern of cytokeratins 7 and 20. Herein, the clinical usefulness of immunohistochemical staining using cytokeratins for making a differential diagnosis of the origin of a tumor in the pelvic cavity is demonstrated.


Brain Tumor Pathology | 2003

Immunohistochemical analysis of the p53 family members in human craniopharyngiomas

Hiroyuki Momota; Shingo Ichimiya; Tatsuru Ikeda; Toshiaki Yamaki; Tomoki Kikuchi; Kiyohiro Houkin; Noriyuki Sato

Craniopharyngiomas are intracranial tumors that usually arise in the site around the sella turcica. They are composed of distinctive sheets of epithelial cells showing adamantinomatous or squamous-papillary histologic type. Because little is known about the tumorigenesis of cranio-pharyngiomas, we retrieved samples from 15 tumor cases to investigate the functional significance of the p53 family of transcription factors, which are known to be expressed in various human epithelia. Immunohistochemical analysis of these cases demonstrated similar expression profiles of p53 family members in the two histologic types of the tumor; i.e., strong nuclear expression of p63 was observed in all cell layers, and moderate to intense nuclear expression of p73 was observed in the basal cell layers. In contrast to p63 and p73, the reactivity of an archetypal tumor suppressor, p53, was occasional and weak in the two histologic types. Because p63 was widely expressed in the tumors, reverse transcription-polymerase chain reaction (RT-PCR) analysis was conducted to elucidate which spliced variant of p63 was expressed. The results showed that †Np63, lacking a terminal transactivation domain of p63, was the dominant isoform. Together with the reported evidence that the †Np63 isoform is highly expressed in human squamous-cell carcinomas, these data suggest that the cellular architecture characteristic of the expression of p53 family members may be required for the histogenesis of craniopharyngiomas, where †Np63 has a possible role in maintaining proliferative activity of the tumor cells, like squamous-cell carcinomas in other tissues.


Journal of Cellular Physiology | 1998

Induction of tyrosine aminotransferase of primary cultured rat hepatocytes depends on the organization of microtubules

Tatsuru Ikeda; Norimasa Sawada; Masaaki Satoh; Michio Mori

We investigated the relationship between the expression of tyrosine aminotransferase (TAT) and cytoskeletal systems of cultured rat hepatocytes by using serum‐free culture conditions and changing three factors: (1) the concentration of calcium, (2) the dish‐coating material, and (3) the cell‐plating density. In hepatocytes in low‐calcium medium, induction of TAT by dexamethasone and glucagon was maintained, although cell‐cell adhesion was lost. Hepatocytes on Matrigel formed a nonspreading, spherical shape that provided them with the full extent of TAT activity without cell‐cell adhesion. Hepatocytes plated on collagen at low cell density spread and changed shape, and the induction of TAT activity was markedly reduced. By using confocal laser‐scanning microscopy, we analyzed the three‐dimensional organization of cytoplasmic microtubules of hepatocytes maintaining the ability of TAT induction. Hepatocytes plated on collagen at low cell density possessed the radial filamentous structure of cytoplasmic microtubules. When the spherical shape of hepatocytes was maintained by cultivating cells on Matrigel, a ring‐like structure of cytoplasmic micotubules beneath the plasma membrane was dominant. Moreover, the induction of TAT activity of hepatocytes in a standard culture system was strongly inhibited by the addition of 1 μM colchicine. These studies suggest that the organization of cytoplasmic microtubules may participate in the shape‐related regulation of cell function. J. Cell. Physiol. 175:41–49, 1998.


Cancer Biology & Therapy | 2005

Aberrant Laminin β3 Isoforms Downstream of EWS-ETS Fusion Genes in Ewing Family Tumors

Hideto Irifune; Hiroyuki Nishimori; Goichi Watanabe; Kouichi Yoshida; Tatsuru Ikeda; Chihiro Matsui; Masaaki Morohashi; Satoshi Kawaguchi; Satoshi Nagoya; Takuro Wada; Toshihiko Yamashita; Yusuke Nakamura; Takashi Tokino

Ewing family tumors (EFTs) are associated with a chromosomal translocation resulting in a fusion of the amino-terminus of EWS with the DNA-binding domain of an ETS transcription factor. Although previous reports suggested that these chimeric proteins would act as aberrant transcription factors, their downstream targets have not been fully elucidated. To identify downstream targets of these EWS-ETS fusion proteins, we introduced EWS-ETS fusion constructs into a human fibrosarcoma cell line, HT-1080, by retroviral transduction. Here we report that the LAMB3 gene encoding the beta-3 chain of basement membrane protein laminin-5 is induced to a significantly higher level in cells expressing EWS-ETSs than in cells expressing normal ETSs. Additionally through use of an antisense oligonucleotide for EWS-ERG in the W-ES EFT cell line, laminin beta-3 protein was reduced coordinately with EWS-ERG fusion protein expression. Furthermore, we found small mRNAs were preferentially transcribed from the LAMB3 gene in EFT cell lines. Molecular cloning of the entire coding region shows that the alternative transcripts from different promoter(s) located within the intron 14, which encode small proteins, likely are major products of the LAMB3 gene in EFT cells. We show that the small isoforms conferred increased anchorage-independent proliferation to NIH3T3 cells. Together with previous studies showing that laminin-5 is involved in the invasive and malignant phenotype of several tumor types, our data suggest that the oncogenic effect of EWS-ETS may be mediated in part by up-regulation of LAMB3 expression.


Medical Molecular Morphology | 1999

Electron microscopic and immunohistochemical studies of gastrointestinal stromal tumors

Jun Yamaguchi; Norimasa Sawada; Hirotoshi Tobioka; Reiko Takakuwa; Tomoko Goto; Yuji Sakuma; Tatsuru Ikeda; Masaaki Satoh; Michio Mori

Sixteen gastrointestinal stromal tumors (GISTs) were studied by immunohistochemical analysis and an ultrastructural procedure. The tumor locations were as follows: esophagus (2), stomach (7), small intestine (3), and large intestine (4). Four of the lesions were classified as malignant, 2 as borderline, and 10 as benign. On the basis of the immunohistochemical analysis, the tumors were classified as follows: 1 as myogenic type, 2 as Schwann cell type, 8 as Cajal cell type (including 2 gastrointestinal autonomic nerve tumors, GANTs), and 5 as mixed-cell type. In each subtype the phenotype was compared to the ultrastructural findings. Myogenic and Schwann cell type revealed ultrastructurally smooth muscle differentiation and schwannian tumor. All 8 tumors of the Cajal cell type revealed interdigitating cytoplasmic processes with occasional clusters of filopodia. Two tumors were subdivided as GANT. Five tumors of mixed-cell type were composed of a mixture of cells with variable myogenic features or variable neural differentiation. We confirmed in this study that immunohistochemical analysis reflected electron microscopic findings.

Collaboration


Dive into the Tatsuru Ikeda's collaboration.

Top Co-Authors

Avatar

Masaaki Satoh

Sapporo Medical University

View shared research outputs
Top Co-Authors

Avatar

Michio Mori

Sapporo Medical University

View shared research outputs
Top Co-Authors

Avatar

Satoshi Kawaguchi

Sapporo Medical University

View shared research outputs
Top Co-Authors

Avatar

Norimasa Sawada

Sapporo Medical University

View shared research outputs
Top Co-Authors

Avatar

Takuro Wada

Sapporo Medical University

View shared research outputs
Top Co-Authors

Avatar

Noriyuki Sato

Sapporo Medical University

View shared research outputs
Top Co-Authors

Avatar

Satoshi Nagoya

Sapporo Medical University

View shared research outputs
Top Co-Authors

Avatar

Sachiko Kimura

Sapporo Medical University

View shared research outputs
Top Co-Authors

Avatar

Shingo Ichimiya

Sapporo Medical University

View shared research outputs
Top Co-Authors

Avatar

Tomoyuki Ohuchi

Health Sciences University of Hokkaido

View shared research outputs
Researchain Logo
Decentralizing Knowledge